Regulatory approvals are crucial because they provide a structured mechanism to evaluate the risk-benefit profile of new cancer treatments. This ensures that patients have access to therapies that are both safe and effective. Without these rigorous assessments, there would be a higher risk of patients being exposed to ineffective or harmful treatments.